Kalliope Kyriakides
Dermatology · Astoria, NYNPI 1407348816
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 24.7% of the total. 2025 is the largest year on record at $3,253, more than ten times the $100 reported in 2022.
Across 151 payments — averaging $36.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$624
- Regeneron Healthcare Solutions, Inc.$524
- Amgen$325
- Johnson & Johnson$301
- Incyte Corporation$288
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,25196%
- Education$2074%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $1,349 |
| Novartis | 12 | $624 |
| Regeneron Healthcare Solutions, Inc. | 14 | $524 |
| Amgen | 21 | $325 |
| Johnson & Johnson | 6 | $301 |
| Incyte Corporation | 9 | $288 |
| Sanofi | 7 | $253 |
| Dermavant Sciences, Inc. | 14 | $250 |
| Arcutis Biotherapeutics, Inc. | 11 | $196 |
| E.r. Squibb & Sons, L.L.C. | 3 | $166 |
| Galderma Laboratories, L.p. | 4 | $163 |
| Grifols USA, LLC | 1 | $143 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $126 |
| AstraZeneca | 1 | $125 |
| Pfizer | 1 | $100 |
| Sun Pharmaceutical Industries Inc. | 5 | $96 |
| CSL Behring | 1 | $71 |
| Botanix SB Inc | 3 | $62 |
| Cipher Pharmaceuticals US LLC | 1 | $51 |
| Merck | 2 | $49 |
| Merz North America, Inc. | 1 | $34 |
| Journey Medical Corporation | 2 | $30 |
| LEO Pharma Inc. | 1 | $26 |
| Sanofi Pasteur Inc. | 1 | $25 |
| Renalytix AI, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Organon | 1 | $19 |
| UCB, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,458 in reported general payments places this provider in the 60th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 26 | $93,260 |
| Clobetasol Propionate | 45 | $2,829 |
| Fluocinonide | 40 | $1,571 |
| Triamcinolone Acetonide | 90 | $1,334 |
| Ketoconazole | 86 | $1,309 |
| Metronidazole | 18 | $1,022 |
| Clindamycin Phosphate | 26 | $982 |
| Tretinoin | 16 | $976 |
| Halobetasol Propionate | 15 | $651 |
| Hydrocortisone | 69 | $429 |
| Mupirocin | 51 | $427 |
| Doxycycline Hyclate | 16 | $420 |
| Ammonium Lactate | 20 | $290 |
| Econazole Nitrate | 11 | $237 |
| Nystatin | 11 | $167 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Astoria
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
- Joshua ZeichnerNew York$2.1M
- Russell CohenOceanside$2.1M
- Jeffrey LaducaAuburn$1.9M
- Emma GuttmanNew York$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.